Marked discrepancy between coagulometric Protein C activity assays with the pro-thrombotic Protein C Asn2Ile substitution

International Journal of Laboratory Hematology

Volumn 33, Issue 5, 2011, Pages 451-456

  Cooper, P C ^a   Siddiq, S ^b   Morse, C ^b   Nightingale, J ^c   Mumford, A D ^d  

^a Sheffield Haemophilia and Thrombosis Centre ^*  (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anticoagulant activity; Phospholipid; Protein C; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 8; LUPUS ANTICOAGULANT; PROTEIN ASN2ILE; PROTEIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENZYME ACTIVITY; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN VARIANT;

ADULT; AMINO ACID SUBSTITUTION; BLOOD COAGULATION TESTS; FEMALE; HETEROZYGOTE; HUMANS; PROTEIN C; PROTEIN C DEFICIENCY;

EID: 80051952793     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01311.x     Document Type: Article

References (24)

1. Bovill E.G., Tomczak J.A., Grant B., Bhushan F., Pillemer E., Rainville I.R. & Long G.L. (1992) Protein C Vermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 79, 1456-1465.
2. Boyer C., Rothschild C., Wolf M., Amiral J., Meyer D. & Larrieu M.J. (1984) A new method for the estimation of protein C by ELISA. Thrombosis Research 36, 579-589.
3. Cooper P.C., Cooper S.M., Goodfellow K.J., Hickey K.P., Kitchen S. & Makris M. (2008) Evaluation of a new venom-based clotting assay of protein C. International Journal of Laboratory Hematology 30, 437-443.
4. Espana F., Estelles A., Aznar J. & Gilabert J. (1986) Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays. Thrombosis Research 44, 771-782.
5. Faioni E.M., Hermida J., Rovida E., Razzari C., Asti D., Zeinali S. & Mannucci P.M. (2000) Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity. British Journal of Haematology 108, 265-271.
6. Flanders M.M. & Rodgers G.M. (2004) Evaluation of a Russell's viper venom-based protein C assay. Thrombosis and Haemostasis 92, 430-431.
7. Gaussem P., Gandrille S., Duchemin J., Emmerich J., Alhenc-Gelas M., Aillaud M.F. & Aiach M. (1994) Influence of six mutations of the protein C gene on the Gla domain conformation and calcium affinity. Thrombosis and Haemostasis 71, 748-754.
8. Hemker H.C., Giesen P., Al Dieri R., Regnault V., de Smedt E., Wagenvoord R., Lecompte T. & Beguin S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis 33, 4-15.
9. Ireland H., Bayston T., Thompson E., Adami A., Goncalves C., Lane D.A., Finazzi G. & Barbui T. (1995) Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation. Thrombosis and Haemostasis 73, 731-732.
10. Jennings I., Kitchen S., Cooper P.C., Rimmer J.E., Woods T.A. & Preston F.E. (2000) Further evidence that activated protein C resistance affects protein C coagulant activity assays. Thrombosis and Haemostasis 83, 171-172.
11. Khor B. & Van Cott E.M. (2010) Laboratory tests for protein C deficiency. American Journal of Hematology 85, 440-442.
12. Kottke-Marchant K. & Comp P. (2002) Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Archives of Pathology and Laboratory Medicine 126, 1337-1348.
13. Marlar R.A. & Adcock D.M. (1989) Clinical evaluation of protein C: a comparative review of antigenic and functional assays. Human Pathology 20, 1040-1047.
14. Marlar R.A., Adcock D.M. & Madden R.M. (1990) Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification. Thrombosis and Haemostasis 63, 375-379.
15. Martinoli J.L. & Stocker K. (1986) Fast functional protein C assay using Protac, a novel protein C activator. Thrombosis Research 43, 253-264.
16. Mimuro J., Muramatsu S., Kaneko M., Yoshitake S., Iijima K., Nakamura K., Sakata Y. & Matsuda M. (1993) An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG-->GGG). Deteriorated calcium-dependent conformation of the gamma-carboxyglutamic acid domain relevant to a thrombotic tendency. International Journal of Haematology 57, 9-14.
17. de Moerloose P., Reber G. & Bouvier C.A. (1988) Spuriously low levels of protein C with a Protac activation clotting assay. Thrombosis and Haemostasis 59, 543.
18. Nakabayashi T., Mizukami K., Naitoh S., Takeda M., Shikamoto Y., Nakagawa T., Kaneko H., Tarumi T., Mizoguchi I., Mizuno H., Ieko M. & Koike T. (2005) Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor. Thrombosis and Haemostasis 94, 942-950.
19. Preston R.J., Ajzner E., Razzari C., Karageorgi S., Dua S., Dahlback B. & Lane D.A. (2006) Multifunctional specificity of the protein C/activated protein C Gla domain. Journal of Biological Chemistry 281, 28850-28857.
20. Preston R.J., Morse C., Murden S.L., Brady S.K., O'Donnell J.S. & Mumford A.D. (2009) The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity. British Journal of Haematology 144, 946-953.
21. Reitsma P.H., Bernardi F., Doig R.G., Gandrille S., Greengard J.S., Ireland H., Krawczak M., Lind B., Long G.L., Poort S.R., Saito H., Sala N., Witt I. & Cooper D.N. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thrombosis and Haemostasis 73, 876-889.
22. Richards S.M., Olson T. & Keyes L.D. (1990) Quantitative and functional assays compared for determination of zymogen and activated human protein C. Clinical Chemistry 36, 1892-1896.
23. Walenga J.M., Fasanella A.R., Iqbal O., Hoppensteadt D.A., Ahmad S., Wallis D.E. & Bakhos M. (1999) Coagulation laboratory testing in patients treated with argatroban. Seminars in Thrombosis and Hemostasis 25(Suppl 1), 61-66.
24. Walker P.A., Bauer K.A. & McDonagh J. (1989) A simple, automated functional assay for protein C. American Journal of Clinical Pathology 92, 210-213.